Page 91 - 2021 Taiwan Food and Drug Administration Annual Report

July July 28 Co-hosted the “2020 APEC GRM Steering Committee”
August August 7 webex meeting with MHLW/PMDA and invited experts and
regulators to jointly discuss about the preliminary thoughts
August 29 of the “APEC GRM Post- 2020 Vision”, in order to plan for
the future implementation of the GRM Roadmap.
August 29 to
September 11 Taiwan Premium Agricultural Products Development
Institute became the fifth certification body for food
September September 8 hygiene and safety management system accredited by
to September 9 the Agency.
September 9
September 9 Collaborated with the Biomedical Translation Research
to September 11 Center of the Academia Sinica to organize the “2020
Pharmaceutical Regulatory Science Review Seminar”
September 15 to enable attendees to understand the domestic
pharmaceutical regulations and counseling directions on
medicinal products projects and discuss drug reviews
and practical cases, to benefit domestically developed
drugs meet the regulatory requirements and can be
launched on the market as soon as possible, further to
EHQH¿W GRPHVWLF SDWLHQWV

Held the “2020 APEC Medical Devices Regulatory
Science Center of Excellence Workshop” in the forms
of online courses and meetings to train 61 seed
instructors from 14 countries of the APEC to facilitate
the harmonization of international medical device
regulations.

Organized the “2020 Food and Drug Inspection Technical
Exchange Consensus Workshop” and invited local health
bureaus to exchange and discuss ideas on the keynote
speeches about food chemical inspection, food biological
inspection, food adulteration and additives, and drugs
and cosmetics inspection.

TFDA and the Taiwan Drug Relief Foundation jointly
organized the “Drug Safety Surveillance Seminar”.

Participated in the Pharmaceuticals and Medical Devices
Agency (PMDA) - Asia Training Center (ATC) Quality
Control online courses “PMDA-ATC Quality Control
Webinar 2020” which introduced topics such as drug
review specifications and quality control to improve
the review capacity of drug reviewers from regulatory
agencies in various countries.

Participated in the 2020 Center for Innovation in
Regulatory Science (CIRS) international workshop
(online). The topic was the “Effectiveness of the
Regulatory Approval Process - Moving from measuring
performance to operational excellence”. The Agency
shared its strategy and practical experience on the
management of review efficiency, which was helpful
for TFDA to optimize its internal review efficiency and
collaborations with the drug administration agencies of
various countries.

89